AAAAAA

   
Results: 1-18 |
Results: 18
WHATS IN A NAME (VOL 24, PG 27, 1998)
Authors: CALLANDER N DESMOND N
Citation: N. Callander et N. Desmond, WHATS IN A NAME (VOL 24, PG 27, 1998), British journal of family planning, 24(2), 1998, pp. 42-42
WHATS IN A NAME
Authors: CALLANDER N DESMOND N
Citation: N. Callander et N. Desmond, WHATS IN A NAME, British journal of family planning, 24(1), 1998, pp. 27-28
URSODIOL PROPHYLAXIS AGAINST HEPATIC COMPLICATIONS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL
Authors: ESSELL JH SCHROEDER MT HARMAN GS HALVORSON R LEW V CALLANDER N SNYDER M LEWIS SK ALLERTON JP THOMPSON JM
Citation: Jh. Essell et al., URSODIOL PROPHYLAXIS AGAINST HEPATIC COMPLICATIONS OF ALLOGENEIC BONE-MARROW TRANSPLANTATION - A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL, Annals of internal medicine, 128(12), 1998, pp. 975
ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION
Authors: TSAI T GOODMAN S SAEZ R SCHILLER G ADKINS D CALLANDER N WOLFF S FREYTES CO
Citation: T. Tsai et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS TRANSPLANTATION, Bone marrow transplantation, 20(10), 1997, pp. 859-863
AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA
Authors: FREYTES CO VUKELJA S SALZMAN D TSAI T CALLANDER N GOKMEN E RODRIGUEZ T CASTRO J BOLDT D ROODMAN GD HILSENBECK S ADKINS D BACHIER C CRAIG F CLARE N WEISNER A LEMAISTRE CF
Citation: Co. Freytes et al., AUTOLOGOUS HEMATOPOIETIC STEM-CELL TRANSPLANTATION FOR POOR-PROGNOSISLOW-GRADE LYMPHOMA, Experimental hematology, 24(9), 1996, pp. 629-629
CLIMAX OVER LAKE GENEVA
Authors: CALLANDER N
Citation: N. Callander, CLIMAX OVER LAKE GENEVA, British journal of family planning, 22(1), 1996, pp. 33-33
ADAPT OR PERISH - THE CHALLENGE TO CLINICS
Authors: CALLANDER N DAWSON S ROCHE C
Citation: N. Callander et al., ADAPT OR PERISH - THE CHALLENGE TO CLINICS, British journal of family planning, 21(4), 1996, pp. 155-155
MANOMETRIC ASSESSMENT OF THE EFFECT OF THE DIAPHRAGMATIC CRURAL SLINGIN GASTROESOPHAGEAL REFLUX - IMPLICATIONS FOR SURGICAL-MANAGEMENT
Authors: PECK N CALLANDER N WATSON A
Citation: N. Peck et al., MANOMETRIC ASSESSMENT OF THE EFFECT OF THE DIAPHRAGMATIC CRURAL SLINGIN GASTROESOPHAGEAL REFLUX - IMPLICATIONS FOR SURGICAL-MANAGEMENT, British Journal of Surgery, 82(6), 1995, pp. 798-801
LAPAROSCOPIC PHYSIOLOGICAL ANTIREFLUX PROCEDURE - PRELIMINARY-RESULTSOF A PROSPECTIVE SYMPTOMATIC AND OBJECTIVE STUDY
Authors: WATSON A SPYCHAL RT BROWN MG PECK N CALLANDER N
Citation: A. Watson et al., LAPAROSCOPIC PHYSIOLOGICAL ANTIREFLUX PROCEDURE - PRELIMINARY-RESULTSOF A PROSPECTIVE SYMPTOMATIC AND OBJECTIVE STUDY, British Journal of Surgery, 82(5), 1995, pp. 651-656
NOVEL-APPROACH TO RELAPSED ACUTE MYELOGENOUS LEUKEMIA (AML) FOLLOWINGBONE-MARROW TRANSPLANTATION (BMT)
Authors: LEWIS S HALVORSON R THOMPSON J SCHROEDER M CALLANDER N
Citation: S. Lewis et al., NOVEL-APPROACH TO RELAPSED ACUTE MYELOGENOUS LEUKEMIA (AML) FOLLOWINGBONE-MARROW TRANSPLANTATION (BMT), Blood, 86(10), 1995, pp. 2247-2247
BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA USING CYCLOPHOSPHAMIDE AND ANTITHYMOCYTE GLOBULIN (ATG)
Authors: SHAUGHNESSY P LEWIS S SCHROEDER M ALLERTON J WILKS S CHRISTMAN K OSSWALD M ABBOTT K HARMON G HALVORSON R SNYDER M CALLANDER N
Citation: P. Shaughnessy et al., BONE-MARROW TRANSPLANTATION FOR PATIENTS WITH SEVERE APLASTIC-ANEMIA USING CYCLOPHOSPHAMIDE AND ANTITHYMOCYTE GLOBULIN (ATG), Blood, 86(10), 1995, pp. 3849-3849
ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AUTO BMT) IN LYMPHOMAS AND ACUTE-LEUKEMIA
Authors: TSAI T GOODMAN S SCHILLER G ADKINS D CALLANDER N WOLFF S FREYTES C
Citation: T. Tsai et al., ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO BMT) FOR RELAPSE AFTER AUTOLOGOUS BONE-MARROW TRANSPLANTATION (AUTO BMT) IN LYMPHOMAS AND ACUTE-LEUKEMIA, Blood, 86(10), 1995, pp. 3864-3864
AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/
Authors: TSAI T SALZMAN D CLARK G CASTRO J CALLANDER N BOLDT D ROODMAN GD SHERIDANLEOS N WIESNER A ADKINS D HARRIS K RODRIGUEZ T GOKMEN E LEMAISTRE CF FREYTES CO
Citation: T. Tsai et al., AUGMENTED CYCLOPHOSPHAMIDE (C), CARMUSTINE (B) AND ETOPOSIDE (V) + - DACARBAZINE (D) WITH AUTOLOGOUS BONE-MARROW TRANSPLANTATION (BMT) FOR RELAPSED OR REFRACTORY HODGKINS-DISEASE - LOWER PERITRANSPLANT MORTALITY AND ANALYSIS OF PROGNOSTIC FACTORS/, Blood, 86(10), 1995, pp. 3865-3865
A STUDY OF ULTRAVIOLET-B PHOTOPROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: OSSWALD M CALLANDER N JOHNSON M HALVORSON R
Citation: M. Osswald et al., A STUDY OF ULTRAVIOLET-B PHOTOPROPHYLAXIS OF GRAFT-VERSUS-HOST DISEASE IN ALLOGENEIC BONE-MARROW TRANSPLANTATION, Experimental hematology, 22(8), 1994, pp. 695-695
A RANDOMIZED DOUBLE-BLIND TRIAL OF PROPHYLACTIC URSODEOXYCHOLIC ACID (UDCA) VS PLACEBO TO PREVENT VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT)
Authors: ESSELL J SCHROEDER M THOMPSON J HARMAN G HALVORSON R CALLANDER N
Citation: J. Essell et al., A RANDOMIZED DOUBLE-BLIND TRIAL OF PROPHYLACTIC URSODEOXYCHOLIC ACID (UDCA) VS PLACEBO TO PREVENT VENOOCCLUSIVE DISEASE OF THE LIVER (VOD) IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION (BMT), Blood, 84(10), 1994, pp. 10000250-10000250
ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) IN PATIENTS WITH CARDIAC DYSFUNCTION USING BUSULFAN AND ETOPOSIDE
Authors: BANE C HALVORSON R SCHROEDER M CALLANDER N ALLERTON J SNYDER M WILKS S CHRISTMAN K LEWIS S HARMAN G
Citation: C. Bane et al., ALLOGENEIC BONE-MARROW TRANSPLANT (BMT) IN PATIENTS WITH CARDIAC DYSFUNCTION USING BUSULFAN AND ETOPOSIDE, Blood, 84(10), 1994, pp. 10000704-10000704
DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV)PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION
Authors: SCHROEDER M ESSELL J HARMAN G HALVORSON R DOLAN M CALLANDER N SNYDER M WILKS S ALLERTON J THOMPSON J
Citation: M. Schroeder et al., DIRECTED GANCICLOVIR (DHPG) PROPHYLAXIS AGAINST CYTOMEGALOVIRUS (CMV)PNEUMONITIS IN PATIENTS UNDERGOING ALLOGENEIC BONE-MARROW TRANSPLANTATION, Blood, 82(10), 1993, pp. 10000425-10000425
DISTURBANCES OF COAGULATION-FACTORS WITH BONE-MARROW TRANSPLANTATION (BMT) - A POSSIBLE LINK TO THE GENESIS OF VENOOCCLUSIVE DISEASE OF THELIVER (VOD)
Authors: WILKS S ESSELL J MCGLASSON D HARMAN G HALVORSON R CALLANDER N SNYDER M ALLERTON J
Citation: S. Wilks et al., DISTURBANCES OF COAGULATION-FACTORS WITH BONE-MARROW TRANSPLANTATION (BMT) - A POSSIBLE LINK TO THE GENESIS OF VENOOCCLUSIVE DISEASE OF THELIVER (VOD), Blood, 82(10), 1993, pp. 10000623-10000623
Risultati: 1-18 |